Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)
Clinical trial NCT04624243 · COMPLETED
Trial details
- NCT number
- NCT04624243
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2024-06-21
- Enrollment
- 499
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.